
Dr. Manish Singhal
Medical OncologyBreast Cancer / Lung Cancer / Personalised Oncology
Experience: 20 Years active
Location: Noida, India
Dept: Department of Medical Oncology
4.6
Based on 76 patient checkupsMedical Practitioner Biography
Dr. Manish Singhal is a senior medical oncologist at Fortis Hospital Noida, bringing over 20 years of specialised experience in breast cancer, lung cancer and gastrointestinal malignancies. His practice is characterised by a strong commitment to personalised molecularly guided cancer treatment that moves well beyond conventional chemotherapy to encompass the full range of modern precision oncology tools.
Dr. Singhal completed his MBBS, MD in General Medicine and the DM in Medical Oncology – the highest academic qualification available in Indian medical oncology. His training gave him comprehensive expertise in haematological and solid tumour oncology, sharpened over two decades of high-volume clinical practice at one of Noida's foremost hospitals.
Breast cancer is the centrepiece of Dr. Singhal's clinical practice. He manages patients across all stages and molecular subtypes – luminal A/B, HER2-positive, triple-negative – with treatment strategies informed by genomic testing, molecular profiling and multigene assays such as Oncotype DX and MammaPrint. His expertise in HER2-targeted therapy – trastuzumab, pertuzumab, T-DM1, trastuzumab deruxtecan – and CDK4/6 inhibitors for hormone receptor-positive disease reflects a practice at the cutting edge of systemic breast cancer treatment.
In lung cancer, Dr. Singhal is expert in molecular-guided treatment for patients with EGFR mutations, ALK/ROS1 rearrangements, KRAS G12C, MET exon 14 alterations and other actionable genomic variants. He has extensive experience with first, second and third-generation EGFR inhibitors and with PD-1/PD-L1 immunotherapy in biomarker-selected and unselected lung cancer populations.
A committed clinical researcher, Dr. Singhal participates in national and international oncology clinical trials through Fortis Noida's programme, giving patients access to investigational agents and novel combinations unavailable through standard care. He presents regularly at ASCO and ESMO annual meetings and has published in peer-reviewed oncology journals on breast and lung cancer treatment.
His patient-centred approach – combining scientific rigour in treatment selection with empathetic transparent communication at every stage of the cancer journey – has made him one of Noida's most trusted oncologists. Dr. Manish Singhal at Fortis Hospital Noida offers patients in Delhi NCR personalised precision oncology, clinical trial access and compassionate care that complex malignancy demands.
Areas of Clinical Expertise
Breast Cancer
Lung Cancer
GI Malignancies
Immunotherapy
Targeted Therapy
CDK4/6 Inhibitors
EGFR Inhibitors
Clinical Trials
Major Interventional Procedures
ChemotherapyTargeted TherapyCheckpoint ImmunotherapyCDK4/6 InhibitorsEGFR InhibitorsALK InhibitorsClinical Trial Enrolment
International Medical Tenures
- International oncology training
- Regular at ASCO ESMO congresses
- International clinical trial collaboration
Professional Fellowships & Memberships
• American Society of Clinical Oncology ASCO
• ISMPO
• European Society for Medical Oncology ESMO
• Indian Cooperative Oncology Network ICON
Practice Matrix
Consultation Fee
$2,000 USD / session
Primary Affiliation
Fortis Hospital, Noida
Noida, India
Qualifications
MBBS; MD General Medicine; DM Medical Oncology
Language Fluency
EnglishHindi
Major Recognitions
🏆 Best Oncologist – Fortis Group Award🏆 ISM Young Oncologist Award🏆 Fortis Clinical Excellence Recognition
Profile Reference URL
https://www.gdhealthcare.com/doctors/dr-manish-singhalUrgent Assistance
Hotline: +91 9999 999 999
Desk: info@gdhealthcare.in